Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mariana Gonzalez Pernas"'
Autor:
María Victoria Ortuño, Débora Katz, Mariela Del Valle Luna, Mariana Gonzalez Pernas, Fabián Pitoia, Amelia Rogozinski, Mariela Glerean, Alejandra Furioso, Julieta Tkatch, Mirtha Guitelman, Sabrina Diez, Karina Danilowicz, Soledad Sosa, Karina Miragaya, Patricia Slavinsky, Elizabeth Bamberger, Nicole Lemaitre, Adriana Reyes, Daniel Moncet, Alicia Lowenstein, Constanza Fernanda Ramacciotti, María Paz Martínez, Analía Pignatta, Patricia Fainstein-Day
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 6, Iss 1, Pp 1-7 (2020)
Clinical Diabetes and Endocrinology
Clinical Diabetes and Endocrinology
Background Acromegaly is associated with higher morbidity and mortality mainly due to cardiovascular disease. Data on the incidence and evolution of thyroid cancer in acromegaly are controversial. Our objective was to describe the characteristics of
Autor:
Patricia, Slavinsky, Mariana, Gonzalez Pernas, Karina, Miragaya, Julio, Antico, Alejandro, Margni, Mariana, Condomí Alcorta, Débora A, Katz
Publikováno v:
Medicina. 82(1)
Stereotactic radiosurgery with gamma knife (GKS) is a treatment option for persistent or recurrent pituitary adenoma. The aim of our study was to report Argentine experience in GKS, assessing the efficacy and safety in our patients with pituitary ade
Autor:
Mariana Gonzalez Pernas, Carolina Ballarino, Karina Danilowicz, Karina Miragaya, Alfieri Analia, Mirtha Guitelman, Débora Katz, Gabriela Szuman, Alejandra Furioso, María Florencia Battistone, Monica Graciela Loto, Julieta Tkatch, Susana Mallea Gil, Soledad Sosa, Mariela Glerean, Amelia Rogozinski, Nicolas Marcelo Vitale, Patricia Slavinsky, Alberto Chervin, Maria Isabel Sabaté, Patricia Fainstein Day
Publikováno v:
Journal of the Endocrine Society
Introduction: Pituitary Metastases (MTS) are infrequently seen in clinical practice. The incidence ranges from 0.14 to 28%. Breast and lung cancer are the primary sites that most frequently metastasize to sellar region, between the sixth and seventh
Autor:
Mariana Gonzalez Pernas, M Manavela, Santiago González Abbati, Oscar D. Bruno, Karina Danilowicz, Soledad Sosa
Publikováno v:
Journal of the Endocrine Society
Prolactinomas represent approximately 40-60% of all pituitary tumors. Dopamine agonists (DA) are the first-line treatment, with a 70-90% response. However, up to 10% are resistant (R) to DA. Our objectives were to describe the clinical, biochemical a